SCHEMBL29453706

SCHEMBL29453706

N#CC1(Cc2cc(F)ccc2F)CCN(C(=O)c2cccnc2-c2ccncn2)CC1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CYP46A1 Q9Y6A2 7/20 0.56
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C8 P10632 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ ALDH1A1 P00352 6/20 0.41
▸ KDM4E B2RXH2 1/20 0.37
▸ HTR2A P28223 3/20 0.37
▸ HTR2C P28335 3/20 0.37
▸ KCNH2 Q12809 1/20 0.37
▸ RIPK1 Q13546 1/20 0.36
▸ KCNK3 O14649 1/20 0.36
▸ HTR1A P08908 1/20 0.36
▸ DRD2 P14416 1/20 0.36
▸ ADRA1A P35348 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22719375 1.00 CYP46A1 (0.56) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453755 0.93 CYP46A1 (0.56) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719423 0.93 CYP46A1 (0.56) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719456 0.90 CYP46A1 (0.53) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453672 0.90 CYP46A1 (0.53) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719224 0.89 CYP46A1 (0.54) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453697 0.89 CYP46A1 (0.58) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719482 0.89 CYP46A1 (0.58) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453654 0.89 CYP46A1 (0.54) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL24710216 0.89 CYP46A1 (0.53) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3976186-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USE Sage Therapeutics, Inc. (US) 2022-04-06 — — EP disclosed
Send feedback